Immunovant
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Immunovant's balance sheet done over the years? Its assets were worth $666,365,000 last year, which is more than in the previous period. 7% of Immunovant’s total assets is currently financed by debt. Its liabilities reached the amount of $48,608,000, which means an increase by 12% compared compared to last year.
Debt to Assets
| 2020 | 109387000 | 15.31M | 14% |
|---|---|---|---|
| 2021 | 412489000 | 21.00M | 5.09% |
| 2022 | 515564000 | 45.73M | 8.87% |
| 2023 | 405838000 | 43.34M | 10.68% |
| 2024 | 666365000 | 48.60M | 7.29% |
IMVT Balance Sheet (2020 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
Assets | |||||
Current assets: | |||||
Cash and cash equivalents | 635.36M | 376.53M | 493.81M | 400.14M | 100.57M |
Short term investments | 0 | 0 | 0 | 0 | 0 |
Net receivables | 5.50M | 885K | 12.86M | 548K | 3.04M |
Inventory | 0 | -5 | -5 | 5 | 0 |
Other current assets | 24.90M | 26.91M | 6.25M | 8.31M | 5.46M |
Total current assets | 665.77M | 404.33M | 512.93M | 409.00M | 109.07M |
Non-current assets: | |||||
Property, Plant and Equipment | 595K | 1.50M | 2.63M | 3.48M | 65K |
Goodwill | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 0 | 0 | 0 | 0 | 246K |
Total non-current assets | 595K | 1.50M | 2.63M | 3.48M | 311K |
Total assets | 666.36M | 405.83M | 515.56M | 412.48M | 109.38M |
Liabilities | |||||
| Current liabilities: | |||||
Accounts payable | |||||
Deferred revenue | 0 | 0 | 0 | 0 | -3.19M |
Short term debt | 276K | 1.17M | 1.14M | 1.17M | 3.19M |
Total current liabilities | 48.60M | 43.29M | 44.52M | 18.77M | 15.31M |
| Non-current liabilities: | |||||
Long term debt | 0 | 47K | 1.21M | 2.23M | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | -347K | 0 | 0 | 0 | 14.12M |
Total non-current liabilities | 0 | 47K | 1.21M | 2.23M | 14.12M |
Total liabilities | 48.60M | 43.34M | 45.73M | 21.00M | 15.31M |
| Data source | Data source | Data source | Data source | Data source |